With 30 March 2019 approaching, the possibility of a no-deal Brexit is still very likely. What happens if a no-deal Brexit occurs? At Factory-CRO we have been thinking a lot about that scenario. Below are six key areas to consider...
Our deep understanding of U.S. and European regulatory agencies ensures your study is designed to meet all pre- and post-market approval requirements. We can assist you with regulatory submissions and study progress reporting.Read more
Our clinical team has extensive experience and knowledge in the clinical trial field, including monitoring & source document verification, trial document handling, and site visits (pre-study, initiation & close out).Read more
Factory’s expert team of medical writers can support you in various ways, including clinical study design, protocol development, clinical evaluation, reporting of study results, and Investigator’s Brochure writing.Read more
Our reimbursement strategy support services are available from conception through product launch and beyond.Read more
With Factory’s acquisition of MileStone Research Organization in San Diego — combined with our offices in Princeton, N.J.; Austin, Texas; Minneapolis and the San Francisco Bay area — we now offer a full range of clinical operations, regulatory, reimbursement and strategic development services in the U.S.Read More